{"acquisitions":[],"changes":[],"country":"US","description":"Kardigan develops cardiovascular drugs personalized to individual disease drivers, with a late-stage portfolio for genetic dilated cardiomyopathy, severe hypertension, and calcific aortic valve stenosis. It treats cardiovascular patients underserved by one-size-fits-all therapies. Kardigan stratifies patients by molecular profile.","domain":"kardigan.bio","employees":null,"founded":2025,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":37.65354,"lng":-122.416866,"location":"South San Francisco, CA","multiples":[],"name":"Kardigan","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":254000000,"connectionsAmong":[],"currency":"USD","date":"2025-10-14","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"kardigan-bio-2025-10-14-series-b","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-14","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"kardigan-bio","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-14","status":"attributed","url":null},{"fact":"existence","publisher":"kardigan.bio","retrievedAt":"2026-05-14","status":"self-reported","url":"https://kardigan.bio"},{"fact":"description","publisher":"kardigan.bio","retrievedAt":"2026-05-14","status":"self-reported","url":"https://kardigan.bio"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","WordPress","Typekit","Adobe Fonts","Yoast SEO 27.4","reCAPTCHA","Google Analytics","Google Tag Manager","FitVids.JS","Font Awesome","jQuery Migrate","Cloudflare Bot Management"],"totalRaisedUsd":554000000,"traction":[],"updatedAt":"2026-05-14","valuations":[]}